October 2, 2026
Starting an antidepressant often comes with the hope that depression will begin to feel more manageable. For some people, treatment leads to meaningful improvement. For others, symptoms improve only partially, return after a period of improvement, or do not improve enough in the first place.
If you are wondering, “Why are my antidepressants not working?”, it does not necessarily mean that depression cannot be treated. It may mean that your current treatment needs more time, the medication or dose needs to be reconsidered, another condition is affecting your symptoms, or a different treatment approach may be appropriate.
It is also important not to stop or change an antidepressant on your own. Abruptly discontinuing some antidepressants can cause withdrawal symptoms and may worsen or complicate symptoms.
Here is what to know when depression medication is not working as expected, including possible reasons, signs that treatment may need to be reevaluated, and what a psychiatrist may consider next.
Improvement from antidepressant treatment does not always feel dramatic.
For some people, early progress may show up as changes in sleep, appetite, energy, concentration, motivation, or ability to complete everyday responsibilities before they notice a substantial improvement in mood.
Signs that treatment may be helping can include:
The goal of treatment is not simply to produce a temporary change in mood. A clinician will generally consider both symptoms and overall functioning when evaluating treatment response.
One reason people conclude that an antidepressant is not working is that they expect improvement immediately.
Antidepressants generally do not work like medications that produce an obvious effect shortly after taking a dose. Depending on the medication and the individual, meaningful improvement may take several weeks.
Some symptoms may begin improving before others.
The amount of time needed to adequately evaluate a medication depends on factors such as the specific antidepressant, dose, consistency of use, side effects, diagnosis, and individual clinical circumstances.
If you have recently started treatment and are concerned about your progress, discuss the expected timeline with your prescribing clinician rather than changing the medication yourself.
There is a difference between a medication doing absolutely nothing and providing an incomplete response.
Treatment may deserve reevaluation when:
These signs do not automatically mean the medication has failed.
They are reasons to discuss your response with your psychiatrist or other prescribing clinician.
There is rarely one explanation that applies to everyone.
Several factors can influence whether depression improves with a particular antidepressant.
If treatment was started recently, there may not yet have been enough time to evaluate the medication fairly.
Stopping too early can make an otherwise potentially useful medication appear ineffective.
Your prescriber can tell you what timeframe is appropriate for the medication you are taking.
Medication response can depend partly on dose.
In some situations, a clinician may determine that a dose adjustment is appropriate. In others, increasing the dose may not be advisable because of side effects, medical considerations, or characteristics of the medication.
Never increase an antidepressant dose on your own.
Medication changes should be discussed with the prescribing clinician.
People can respond differently to antidepressants.
A medication that works well for one person may provide limited benefit or cause unacceptable side effects for another.
An inadequate response to one antidepressant does not necessarily predict how someone will respond to every other treatment.
Your psychiatrist may review your previous treatment response when considering whether a different medication or treatment strategy makes sense.
Antidepressant treatment is not always an all-or-nothing experience.
You may notice that your sleep improves but motivation remains low. Perhaps you feel less hopeless but still struggle with concentration and enjoyment. Or you may function somewhat better while continuing to experience substantial symptoms.
This is often described clinically as a partial response.
Recognizing partial improvement is important because it gives your clinician information about how treatment is affecting you.
Rather than simply telling your psychiatrist that medication “works” or “doesn't work,” try describing exactly which symptoms changed and which did not.
Symptoms associated with depression can overlap with other psychiatric and medical conditions.
For example, difficulties with concentration, sleep, energy, motivation, and emotional functioning can occur in more than one condition.
A psychiatrist may therefore reconsider the broader clinical picture when depression does not respond as expected.
Depending on the individual, an evaluation may consider factors such as:
This does not mean one of these issues is necessarily present.
It means that persistent symptoms sometimes warrant reassessing whether the original treatment plan still fits the overall clinical picture.
Antidepressants generally need to be taken according to the prescribed schedule.
Frequently missing doses or taking medication inconsistently can make it harder to determine whether the treatment is effective.
If you have difficulty remembering medication, tell your clinician rather than feeling embarrassed about it.
That information matters.
It can prevent unnecessary medication changes when the real issue may be consistency, side effects, cost, scheduling, or another barrier that can potentially be addressed.
Sometimes an antidepressant improves depression but causes side effects that make continued treatment difficult.
Depending on the medication and individual, potential side effects can include changes involving:
Do not assume that you simply have to tolerate significant side effects.
Discuss them with your prescriber. The appropriate response depends on the medication, severity of the side effect, benefits of treatment, and individual circumstances.
Some people experience meaningful improvement with an antidepressant and later notice depression symptoms returning.
Patients sometimes describe this as an antidepressant stopping working.
Before concluding that the medication itself has lost effectiveness, a clinician may consider several possibilities.
Questions might include:
The return of symptoms does not automatically mean your previous treatment was useless.
It means the clinical situation deserves reassessment.
Potentially.
Medication does not eliminate every emotional response to difficult circumstances.
Major changes involving relationships, work, finances, grief, health, family responsibilities, or other sources of stress can affect mood even when someone is receiving appropriate treatment.
That does not mean significant symptoms should be dismissed as “just stress.”
Instead, your clinician may need to determine whether you are experiencing an understandable response to circumstances, recurrence or worsening of depression, another psychiatric condition, or a combination of factors.
The most important step is usually to discuss your symptoms with the clinician managing your medication.
Try to provide specific information.
Instead of saying only, “My antidepressant isn't working,” consider explaining:
This gives your clinician much more useful information for determining what may need to change.
Do not abruptly stop a prescribed antidepressant without discussing it with your clinician unless you are receiving emergency medical instructions to do so.
Stopping some antidepressants suddenly can lead to discontinuation symptoms.
Depending on the medication, these can include physical or emotional symptoms that may be uncomfortable and can sometimes be confused with a return of the underlying condition.
If an antidepressant needs to be discontinued, your prescriber can recommend an appropriate plan based on the medication and your circumstances.
The appropriate next step depends on why treatment has not provided enough improvement.
A psychiatrist may reassess the diagnosis, medication history, dose, treatment duration, adherence, side effects, other medications, medical considerations, and severity of remaining symptoms.
Depending on the clinical situation, options may include:
There is no universal “next medication” that is appropriate for everyone.
Treatment decisions should be individualized.
When depression continues despite adequate treatment attempts, clinicians may begin considering whether someone has treatment-resistant depression.
Definitions can vary, but the term generally refers to depression that has not adequately improved despite appropriate antidepressant treatment trials.
Importantly, one antidepressant not working does not automatically mean you have treatment-resistant depression.
A psychiatrist may review:
This treatment history matters because a medication cannot necessarily be considered an adequate treatment trial if it was stopped very early, taken inconsistently, or never reached an appropriate therapeutic plan.
There is no single number that determines the right treatment for every person.
The importance of previous antidepressant trials depends on whether they were adequate, tolerated, and appropriate for the diagnosis.
Someone who stopped two medications after only a few days because of side effects has a different treatment history from someone who completed adequate trials of multiple antidepressants without sufficient improvement.
Rather than counting medications alone, a psychiatrist evaluates the quality and outcome of previous treatment trials.
Treatment-resistant depression does not mean there are no remaining options.
Depending on the individual, a psychiatrist may consider different medication strategies, psychotherapy, other evidence-based interventions, or treatments specifically used in certain patients with treatment-resistant depression.
One option for eligible adults is Spravato® (esketamine).
Spravato is different from conventional oral antidepressants and is administered in a certified healthcare setting under appropriate supervision.
It is not appropriate for everyone, and eligibility requires clinical evaluation.
Saltmeadow Psychiatry provides Spravato treatment for eligible patients with treatment-resistant depression in Savannah, Georgia.
Spravato and ketamine are related, but they are not identical.
Spravato® contains esketamine, which is related to ketamine and is administered as a nasal spray under specific clinical requirements.
Ketamine may be used in different formulations and clinical contexts.
If you are researching options because antidepressants are not working, the distinction matters. A psychiatrist can explain which treatments may be clinically appropriate based on diagnosis, previous treatment history, medical considerations, and other factors.
Saltmeadow Psychiatry's existing Spravato® vs. Ketamine resource provides a more detailed comparison.
Not necessarily.
Psychiatric treatment is often a process of determining which approach provides the best balance of effectiveness, tolerability, and safety for an individual patient.
A medication might provide partial benefit without producing sufficient improvement.
Another may improve depression but cause difficult side effects.
A treatment that helped previously may need to be reconsidered when symptoms return.
These situations provide information that can help guide the next treatment decision.
Effective psychiatric medication management involves more than receiving a prescription.
Follow-up appointments allow your psychiatrist to evaluate:
This ongoing information helps determine whether treatment should remain the same or be reconsidered.
Medication management can be particularly important when several previous treatments have been tried.
If you are seeing a psychiatrist because your depression medication is not working, preparing a brief treatment history can make the appointment more productive.
If possible, gather:
You do not need perfect records.
Pharmacy histories or previous medical records may sometimes help when details are difficult to remember.
If your antidepressant does not seem to be providing enough relief, consider asking:
You should understand why a treatment is being recommended and what you and your clinician will monitor.
Depression can sometimes become an emergency.
Seek immediate help if you are in danger, unable to keep yourself safe, or experiencing thoughts of suicide or self-harm that require urgent support.
In the United States, you can call or text 988 to reach the Suicide & Crisis Lifeline. If there is an immediate danger, call 911 or go to the nearest emergency department.
A routine outpatient appointment should not be used as a substitute for emergency care.
Consider discussing treatment with a psychiatrist or your current prescriber when depression remains significant despite treatment, side effects are difficult to tolerate, symptoms have returned, or you are uncertain whether your medication is helping.
A psychiatric evaluation can help review both the current symptoms and the treatment history.
This can be particularly valuable when you have tried multiple medications or your depression has become difficult to treat.
If your antidepressants are not working as expected, you do not have to determine the next treatment step on your own.
At Saltmeadow Psychiatry, Dr. Daniel Perry, MD, MPH provides individualized psychiatric evaluation and medication management for adults in Savannah, Georgia.
For people experiencing persistent depression, care may include reviewing previous antidepressant treatment, evaluating factors that may be affecting response, and considering appropriate next steps.
Saltmeadow Psychiatry also evaluates eligible patients for Spravato® treatment for treatment-resistant depression.
Treatment recommendations depend on each patient's diagnosis, treatment history, medical considerations, symptoms, and individual needs.
Saltmeadow Psychiatry
9100 White Bluff Rd, Suite 303
Savannah, GA 31406
Phone: (912) 513-2888
Request an Appointment:
https://spruce.care/danielperrymd
There are many possible explanations. The medication may need more time, the dose or medication may need reevaluation, treatment may be providing only partial improvement, medication may be taken inconsistently, or another psychiatric or medical factor may be contributing. A clinician can review your individual circumstances.
Persistent depression symptoms, limited improvement, significant ongoing impairment, difficult side effects, or symptoms returning after initial improvement are reasons to discuss treatment with your prescriber. Treatment response should be evaluated over an appropriate timeframe for the specific medication.
Contact the clinician managing your medication. Explain which symptoms have improved, which remain, any side effects, how consistently you take the medication, and how symptoms affect daily functioning. Do not increase, decrease, or abruptly discontinue your medication without appropriate medical guidance.
The return of symptoms can have multiple explanations, including recurrence of depression, medication adherence, changes in stress, sleep, health, other medications, or additional psychiatric factors. A clinical reassessment can help determine what may be happening.
Some people experience a return of depression symptoms after a period of improvement. This deserves reassessment rather than automatically assuming the medication itself is the only cause.
No. One unsuccessful medication trial does not automatically establish treatment-resistant depression. Clinicians typically review the number and adequacy of previous treatment trials along with diagnosis, adherence, response, and other clinical factors.
A psychiatrist may reassess the diagnosis and previous treatment trials and consider different medication strategies, psychotherapy, contributing medical or psychiatric conditions, or other evidence-based treatment approaches. Certain patients with treatment-resistant depression may also be evaluated for treatments such as Spravato.
Do not abruptly discontinue a prescribed antidepressant without speaking with your clinician. Some medications can cause discontinuation symptoms when stopped suddenly, and an appropriate taper may be needed.
Spravato® (esketamine) may be an option for certain eligible patients with treatment-resistant depression. It is not appropriate for everyone and requires evaluation and administration under specific clinical conditions.
Saltmeadow Psychiatry in Savannah provides psychiatric evaluation, medication management, and Spravato treatment for eligible adults. A psychiatric evaluation can review previous treatment and help determine appropriate next steps.
.png)
